National Taiwan University Hospital, Medical Oncology
Dr Ann-Lii Cheng, is Professor of Medicine and Chief of Medical Oncology of the National Taiwan University Hospital in Taipei, Taiwan. He received his MD degree, PhD degree, and his specialty training in Medical Oncology at the Medical School of the National Taiwan University. In 1990, he was a research fellowat the Comprehensive Cancer Center of the University of Wisconsin, Madison, USA. Dr Cheng has been actively involved in basic and translational research in lymphoma, gastric adenocarcinoma and hepatocellular carcinoma. He has published more than 180 peer-reviewed articles in these areas. He became "Distinguished Professor" of National Taiwan University in 2006, and was elected as Fellow of American Association for the Advancement of Science (AAAS) in 2007. In addition, Dr Cheng is chairman of the Chemotherapy Committee of the Taiwan Cooperative Oncology Group, of which he was the one of the founding members.
Dr Chih-Hsin (James) Yang, MD, PhD, is Professor at the Graduate Institute of Clinical Medicine and the Graduate Institute of Clinical Pharmacy at the College of Medicine, National Taiwan University (NTU), and has been a staff member in the Department of Oncology at the university hospital since 1995. Between 1993 and 1995 he was the clinical associate medical oncologist at the Medicine Branch of National Cancer Institute at Bethesda, Maryland. Dr Yang's research focus is the treatment of lung cancer and the mechanism of multidrug resistance of chemotherapy or targeted therapy. He is the principal investigator of many local and international clinical trials and serves in the steering committee in many international studies on lung cancer. He has published more than 60 papers in international peer-reviewed journals in the fields of multidrug resistance research and lung cancer treatment. He was the invited speaker, organizer in many international symposium and conferences.
A/Prof Kun-Huei Yeh, trained in National Taiwan University Hospital (NTUH) as a medical oncologist, and earned his PhD doctorate degree at the Graduate Institute of Clinical Medicine, NTU College of Medicine, in 1998. From 1998 to 2000, he worked as an associate scholar at the Department of Genetics, Yale School of Medicine, Connecticut, USA, for basic researches in cancer cell cycle control, and protein ubiquitination of p27 and cyclin E. He has been appointed Department Chief of Internal Medicine, and Deputy Superintendent of far Eastern Memorial Hospital between 2001 and 2006. After returning to NTUH he has helped develop a cancer translational research laboratory, and has particular research interests in gastrointestinal cancers (gastric cancer, gastric MALToma, colorectal cancer, esophageal cancer, etc).
Dr Chia-Chi (Josh) Lin, MD, PhD, Staff Physician, Department of Oncology, National Taiwan University Hospital, and Adjunct Assistant Professor, Department of Urology, National Taiwan University College of Medicine. He received his MD degree, PhD degree, and his specialty training in Medical Oncology at the National Taiwan University College of Medicine. In 2006 - 2007, he was a clinical research fellow at the Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX and Clinical Research Services at Scottsdale Healthcare, Translational Genomics Research Institute, Scottsdale, AZ, USA. Dr Lin has been actively involved in clinical and translational research in thoracic malignancies (esophageal cancer, lung cancer), genitourinary malignancies (transitional cell carcinoma, renal cell carcinoma, prostate cancer), and phase I trials. He has published more than 20 peer-reviewed articles and reviews in these areas. Dr Lin is an active member of the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). He has served as add hoc reviewers of Cancer Letters and Asia-Pacific Journal of Clinical Oncology.
Dr Chiun Hsu is a clinical assistant professor and attending physician at the Department of Oncology. His research interest includes clinical and translational research of hepatobiliary cancers.
Dr Chih-Hung Hsu is a clinical assistant professor and attending physician at the Department of Oncology. He received his MD degree and PhD degree at the National Taiwan University College of Medicine, and his specialty training in Medical Oncology at the University Hospital of the same institute. In 2003-2004, he was a research fellow at the Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA. His research interest includes clinical and translational research of liver cancer and esophageal cancer.
Dr Yen-Shen Lu is Adjunct Associate Professor at the Department of Internal Medicine, National Taiwan University College of Medicine in Taipei, Taiwan. He has been an attending doctor at the Department of Oncology, National Taiwan University Hospital since 2001. Dr Lu gained his medical degree from the Chinese Medical College of Medicine in 1992 and his PhD from the institute of Clinical Medicine, National Taiwan University College of Medicine in 2006. Dr Lu has been actively involved in basic and translational research in hepatocellular carcinoma, and breast cancer. He is co-author of more than 30 peer-reviewed articles. Dr Lu is a member of the Taiwan Society of Internal Medicine, the Chinese Oncology Society and the Breast Cancer Society of Taiwan.
Dr Zhong-Zhe Lin, M.D., is a medical oncologist in National Taiwan University Hospital, and is actively participating in translational and clinical researches of liver, lung, and gastric cancers.
Dr Ying-Chun Shen is a medical oncologist and hamatologist. She is involved in designing and conducting many clinical trials of liver, pancreas and stomach cancers. Her main interest of research is hepatocarcinoma.
Dr Ching-Hung Lin is a medical oncologist and hematologist in National Taiwan University Hospital, and is actively participating in translational and clinical researches of breast cancer and lymphoma.
Dr Yu-Lin Lin is a medical oncologist and attending physician in the Department of Onology, National Taiwan University Hospital. He had been a clinical observer in phase I clinical trial center at Ohio State University (OSU) Medical Center and trained for translational research in the college of pharmacy at OSU for one year. His research interest includes clinical and translational research of lung and colorectal cancer.
Dr Jih-Hsiang Lee, an attending physician, completed his fellowship training in the department of oncology, National Taiwan University Hospital, Taiwan. He currently serves in the National Center of Excellence for Clinical Trial and Research, a project of National Taiwan University Hospital, Taiwan.
Yu-Fen Su, Secretary of Oncology Department
Chiao-Wen Huang, Nursing Manager of oncology ward and phase I center.
Jing-Fang Lin, Clinical Trial Manager of national clinical trial and research center.